Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.
Author: Christina Jewett and Pam Belluck
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}